Enviar pesquisa
Carregar
Atherosclerotic plaque: Radionuclide Imaging
•
3 gostaram
•
423 visualizações
A
adamsh
Seguir
Denunciar
Compartilhar
Denunciar
Compartilhar
1 de 21
Recomendados
role of immunohistochemistry in head and neck pathology
Role of ihc
Role of ihc
vellanki sudharshan
Apoptosis
Apoptosis
Apoptosis
Mohammed Fathy
MCC 2011 - Slide 6
MCC 2011 - Slide 6
European School of Oncology
ihc in oncology
Ihc oncology.ppt1
Ihc oncology.ppt1
Dr ABDUL WAHEED DAR
MCC 2011 - Slide 4
MCC 2011 - Slide 4
European School of Oncology
Ascp08 Baltimore
Ascp08 Baltimore
ML Cohen
oncology
Cancer and ihc markers
Cancer and ihc markers
Nilesh Kucha
As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through EMT pathway
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
JuanCamiloPelaezOrti
Recomendados
role of immunohistochemistry in head and neck pathology
Role of ihc
Role of ihc
vellanki sudharshan
Apoptosis
Apoptosis
Apoptosis
Mohammed Fathy
MCC 2011 - Slide 6
MCC 2011 - Slide 6
European School of Oncology
ihc in oncology
Ihc oncology.ppt1
Ihc oncology.ppt1
Dr ABDUL WAHEED DAR
MCC 2011 - Slide 4
MCC 2011 - Slide 4
European School of Oncology
Ascp08 Baltimore
Ascp08 Baltimore
ML Cohen
oncology
Cancer and ihc markers
Cancer and ihc markers
Nilesh Kucha
As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through EMT pathway
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
JuanCamiloPelaezOrti
As a biomarker for gastric cancer, circPTPN22
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
JuanCamiloPelaezOrti
As a biomarker for gastric cancer, circPNTP22 regultes de progression of gastric cancer through the EMT pathway
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
JuanCamiloPelaezOrti
Immunohistochemistry is an important complimentary tool for diagnosis of cancer"
Immunohistochemistry is an important complimentary tool for diagnosis of cancer"
Lawrence Richards
Tumor markers (TMs) refer to a class of substances that are directly produced by tumor cells or other cells of the body in response to tumors during its development and proliferation stages. Tumor markers essentially are proteins, hormones, enzymes (isozymes), polyamines, and oncogene products, which presents in the blood, body fluids, cells or tissues of patients. They can quantitatively and qualitatively reveal the presence of tumors, which provides strong experimental basis to estimate what the type of tumor is, what stage of the tumor has been developed to, the therapeutic effect and prognosis. www.antibody-creativebiolabs.com
Tumor markers-screening-for-cancer
Tumor markers-screening-for-cancer
Creative Biolabs
This is needs to be updated as new Biomarkers and Dx antibodies come into existence in remarkable numbers every day! You have to construct an algorithm based on your need and availability of antibodies. Selection of Antibodies for the algorithm also depends on your ability to recognize the characterization of the specific antibody.
Cancer Dx Algorithm
Cancer Dx Algorithm
Lawrence Richards
Drugs used in Pharmacodiagnostics
Drugs in Pharmacodiagnostics
Drugs in Pharmacodiagnostics
Rajiv S
Molecular mechanism of cancer metastasis
Molecular mechanism of cancer metastasis
Gopi krishna Giri
The lecture documents the basic utility of molecular imaging tools in radiology and nuclear medicine i.e. PET-CT
Molecular imaging
Molecular imaging
Assoc Prof Fathinul Fikri AS
how the cancer is developed? how cancer is spread.
Mechanism of cancer development pdf
Mechanism of cancer development pdf
isa bella
Tyrosin kinase inhibitors
14.tyrosine kinase
14.tyrosine kinase
Dr SANTHIPRIYA GOPASANA
general oncology from devita presentation
Chapter 3.1 tumor angiogneisis
Chapter 3.1 tumor angiogneisis
Nilesh Kucha
Presentation about WNT-signalling, Colon Cancer epidemology and its reasons, existing drug approaches and a Virus-based therapy.
Coloncancer3
Coloncancer3
sol777
antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)
Stephanie Thiede
This is the presentation of a clinical case of Multiple Myeloma with a thorough discussion on many aspects of the disease and on applications of Shear Wave Elastography.
Dr. masciotra shear wave elastography and more in a clinical case of multip...
Dr. masciotra shear wave elastography and more in a clinical case of multip...
antonio pio masciotra
Cytogenetic Analysis in Hematological Malignancies
Cytogenetic Analysis in Hematological Malignancies
spa718
Light chain immunofluorescence in various nephropathies
11. light chain immunofluoresence in various nephropathies
11. light chain immunofluoresence in various nephropathies
Dr SANTHIPRIYA GOPASANA
Role of Immunocytochemistry in body fluids
13. role of icc in body fluids
13. role of icc in body fluids
Dr SANTHIPRIYA GOPASANA
This presentation (in English) made at ONCOTRANS in Besançon on Friday 3rd 2017 reviews the potential for TGF-beta inhibition in hepatocellular carcinoma based on preclinical and clinical data.
ONCOTRANS 2017 - Eric Raymond - TGF-beta inhibition
ONCOTRANS 2017 - Eric Raymond - TGF-beta inhibition
Prof. Eric Raymond Oncologie Medicale
Lecture delivered at CNCI, September, 2013
Immunohistochemistry in Gynaecological Cancers
Immunohistochemistry in Gynaecological Cancers
Sujoy Dasgupta
a new IHC method to detect malignancies with NTRK rearrangments and fusions this ppt sumerizes the newes research done on this topic for your convinence
Pan trk IHC
Pan trk IHC
Danielle Fridrich
MCO 2011 - Slide 30 - K. Öberg - Spotlight session - Neuroendocrine tumours
MCO 2011 - Slide 30 - K. Öberg - Spotlight session - Neuroendocrine tumours
European School of Oncology
5. Carcinoid Tumour Biochemical And Radiological Testing
5. Carcinoid Tumour Biochemical And Radiological Testing
ensteve
Mais conteúdo relacionado
Mais procurados
As a biomarker for gastric cancer, circPTPN22
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
JuanCamiloPelaezOrti
As a biomarker for gastric cancer, circPNTP22 regultes de progression of gastric cancer through the EMT pathway
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
JuanCamiloPelaezOrti
Immunohistochemistry is an important complimentary tool for diagnosis of cancer"
Immunohistochemistry is an important complimentary tool for diagnosis of cancer"
Lawrence Richards
Tumor markers (TMs) refer to a class of substances that are directly produced by tumor cells or other cells of the body in response to tumors during its development and proliferation stages. Tumor markers essentially are proteins, hormones, enzymes (isozymes), polyamines, and oncogene products, which presents in the blood, body fluids, cells or tissues of patients. They can quantitatively and qualitatively reveal the presence of tumors, which provides strong experimental basis to estimate what the type of tumor is, what stage of the tumor has been developed to, the therapeutic effect and prognosis. www.antibody-creativebiolabs.com
Tumor markers-screening-for-cancer
Tumor markers-screening-for-cancer
Creative Biolabs
This is needs to be updated as new Biomarkers and Dx antibodies come into existence in remarkable numbers every day! You have to construct an algorithm based on your need and availability of antibodies. Selection of Antibodies for the algorithm also depends on your ability to recognize the characterization of the specific antibody.
Cancer Dx Algorithm
Cancer Dx Algorithm
Lawrence Richards
Drugs used in Pharmacodiagnostics
Drugs in Pharmacodiagnostics
Drugs in Pharmacodiagnostics
Rajiv S
Molecular mechanism of cancer metastasis
Molecular mechanism of cancer metastasis
Gopi krishna Giri
The lecture documents the basic utility of molecular imaging tools in radiology and nuclear medicine i.e. PET-CT
Molecular imaging
Molecular imaging
Assoc Prof Fathinul Fikri AS
how the cancer is developed? how cancer is spread.
Mechanism of cancer development pdf
Mechanism of cancer development pdf
isa bella
Tyrosin kinase inhibitors
14.tyrosine kinase
14.tyrosine kinase
Dr SANTHIPRIYA GOPASANA
general oncology from devita presentation
Chapter 3.1 tumor angiogneisis
Chapter 3.1 tumor angiogneisis
Nilesh Kucha
Presentation about WNT-signalling, Colon Cancer epidemology and its reasons, existing drug approaches and a Virus-based therapy.
Coloncancer3
Coloncancer3
sol777
antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)
Stephanie Thiede
This is the presentation of a clinical case of Multiple Myeloma with a thorough discussion on many aspects of the disease and on applications of Shear Wave Elastography.
Dr. masciotra shear wave elastography and more in a clinical case of multip...
Dr. masciotra shear wave elastography and more in a clinical case of multip...
antonio pio masciotra
Cytogenetic Analysis in Hematological Malignancies
Cytogenetic Analysis in Hematological Malignancies
spa718
Light chain immunofluorescence in various nephropathies
11. light chain immunofluoresence in various nephropathies
11. light chain immunofluoresence in various nephropathies
Dr SANTHIPRIYA GOPASANA
Role of Immunocytochemistry in body fluids
13. role of icc in body fluids
13. role of icc in body fluids
Dr SANTHIPRIYA GOPASANA
This presentation (in English) made at ONCOTRANS in Besançon on Friday 3rd 2017 reviews the potential for TGF-beta inhibition in hepatocellular carcinoma based on preclinical and clinical data.
ONCOTRANS 2017 - Eric Raymond - TGF-beta inhibition
ONCOTRANS 2017 - Eric Raymond - TGF-beta inhibition
Prof. Eric Raymond Oncologie Medicale
Lecture delivered at CNCI, September, 2013
Immunohistochemistry in Gynaecological Cancers
Immunohistochemistry in Gynaecological Cancers
Sujoy Dasgupta
a new IHC method to detect malignancies with NTRK rearrangments and fusions this ppt sumerizes the newes research done on this topic for your convinence
Pan trk IHC
Pan trk IHC
Danielle Fridrich
Mais procurados
(20)
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Seminario Alejandro Páez Sequeda - Juan Camilo Peláez Ortiz
Immunohistochemistry is an important complimentary tool for diagnosis of cancer"
Immunohistochemistry is an important complimentary tool for diagnosis of cancer"
Tumor markers-screening-for-cancer
Tumor markers-screening-for-cancer
Cancer Dx Algorithm
Cancer Dx Algorithm
Drugs in Pharmacodiagnostics
Drugs in Pharmacodiagnostics
Molecular mechanism of cancer metastasis
Molecular mechanism of cancer metastasis
Molecular imaging
Molecular imaging
Mechanism of cancer development pdf
Mechanism of cancer development pdf
14.tyrosine kinase
14.tyrosine kinase
Chapter 3.1 tumor angiogneisis
Chapter 3.1 tumor angiogneisis
Coloncancer3
Coloncancer3
antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)
Dr. masciotra shear wave elastography and more in a clinical case of multip...
Dr. masciotra shear wave elastography and more in a clinical case of multip...
Cytogenetic Analysis in Hematological Malignancies
Cytogenetic Analysis in Hematological Malignancies
11. light chain immunofluoresence in various nephropathies
11. light chain immunofluoresence in various nephropathies
13. role of icc in body fluids
13. role of icc in body fluids
ONCOTRANS 2017 - Eric Raymond - TGF-beta inhibition
ONCOTRANS 2017 - Eric Raymond - TGF-beta inhibition
Immunohistochemistry in Gynaecological Cancers
Immunohistochemistry in Gynaecological Cancers
Pan trk IHC
Pan trk IHC
Semelhante a Atherosclerotic plaque: Radionuclide Imaging
MCO 2011 - Slide 30 - K. Öberg - Spotlight session - Neuroendocrine tumours
MCO 2011 - Slide 30 - K. Öberg - Spotlight session - Neuroendocrine tumours
European School of Oncology
5. Carcinoid Tumour Biochemical And Radiological Testing
5. Carcinoid Tumour Biochemical And Radiological Testing
ensteve
Simple introduction to fdg pet imaging
Basics and principles of PET.pptx
Basics and principles of PET.pptx
OlaAttieh2
MCO 2011 - Slide 18 - M.R. Alison - Joint medics and nurses spotlight session...
MCO 2011 - Slide 18 - M.R. Alison - Joint medics and nurses spotlight session...
European School of Oncology
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...
European School of Oncology
Insight about Nuclear medicine
Nuclear medicine
Nuclear medicine
Vharshini Manoharan
2014 MFDS Global Biopharmaceutical Forum: "Clinical and Preclinical Researches in Human Pluripotent Stem Cells" Human ES Cell Product – RPE Program for Blindness (CHA & ACT-Ocata) 2014 MFDS Meeting - 2014. 7. 9~10. Hyung Min Chung Konkuk University, College of Medicine, Seoul, Korea
2 2. hyung min chung ppt
2 2. hyung min chung ppt
John Redaelli
Provenge (Sipuleucel T)
Provenge (Sipuleucel T)
Cytokinine
Los días 15 y 16 de octubre de 2014, la Fundación Ramón Areces y la Real Academia Nacional de Farmacia, en colaboración con la Fundación de la Innovación Bankinter, reunieron en Madrid a algunos de los mayores expertos mundiales en nuevas terapias contra el cáncer. El Simposio Internacional, coordinado por la profesora y académica María José Alonso, analizó el momento actual de la lucha contra esta enfermedad. También fue un punto de encuentro para científicos de los más innovadores institutos de investigación en oncología, quienes debatieron sobre tres grandes temas: la Medicina Personalizada contra el cáncer, los nanomedicamentos en la terapia del cáncer y las terapias basadas en la inmunomodulación.
Dr. Carlos García Echeverría - Simposio Internacional 'Terapias oncológicas a...
Dr. Carlos García Echeverría - Simposio Internacional 'Terapias oncológicas a...
Fundación Ramón Areces
Discovery of novel immunotherapy represents a main and intense focus of reseach in oncology. Proof of concept studies in animal represent a challenge and require a well characterized and appropriate animal models with most of the time customized approaches. Some recent developments and data generated for immune checkpoint modulators, adoptive cell transfer therapy, vaccines and bispecific T cell engagers will be presented.
From syngenic to_humanised_models_mirjolet_oncodesign
From syngenic to_humanised_models_mirjolet_oncodesign
Florence Fombertasse
A novel platform for in situ, multiomic, hyper-plexed analyses of systems bio...
A novel platform for in situ, multiomic, hyper-plexed analyses of systems bio...
Rafael Casiano
Provenge (sipuleucel t)
Provenge (sipuleucel t)
Vinblast
Advanced prostate cancer is highly heterogeneous but this inter-patient heterogeneity has until recently not been understood. We have through an international research effort dissected the molecular landscape of advanced castration resistant prostate, elucidating key molecular targets in this group of diseases. We have also shown that PARP inhibitors have antitumor activity against a significant proportion of these cancers, mainly in men whose cancers harbor DNA repair defects.
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
QIAGEN
Eduardo Marbán, MD, PhD gives a deep dive into the complexities of regenerative cardiovascular medicine and the future directions for cell therapies. Dr. Marbán’s lab has found several noncoding RNA (ncRNA) species, including short Y RNAs, which themselves have intriguing biological actions. The ncRNA within extracellular vesicles can either be used as they occur naturally or serve as bioinspiration for new chemical entities. The next generations of cell-free biologics (extracellular vesicles and noncoding RNAs) may provide, or even transcend, the benefits of cell therapy without the intrinsic limitations. Key Topics Include: - Understand the current status of cell therapy for heart disease - Review the mechanisms whereby cells exert their therapeutic benefits - Explore the future of RNA drugs inspired by the contents of extracellular vesicles
Cardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics
Cardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics
InsideScientific
Dr. Richard Cote of Sylvester Comprehensive Cancer Center presented "New Technologies That Will Have an Impact on Cancer" at the 2011 WellBeingWell Conference in Miami.
Nanotechnology in Cancer - Dr. Cote
Nanotechnology in Cancer - Dr. Cote
Sylvester Comprehensive Cancer Center
https://www.snmclub.com/presentation Update in breast imaging Radiopharmaceuticals Al Rowaily Mohammed, MSc, CRP, PhD icrm2018
Update in Breast Imaging Radiopharmaceuticals
Update in Breast Imaging Radiopharmaceuticals
@Saudi_nmc
Patricia Steeg, PhD, Chief of Women's Cancers Section at the Center for Cancer Research at NCI, will present her novel research relating to metastatic breast cancer, including the development of experimental models of brain metastasis. Join SHARE and Dr. Steeg for this nformative webinar.
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
bkling
Development of a high throughput in vitro screening platform to identify novel inducers of immunological cell
Development of a high throughput in vitro screening platform to identify nove...
Development of a high throughput in vitro screening platform to identify nove...
Oncodesign
El 14 de noviembre de 2016, la Fundación Ramón Areces organizó un Simposio Internacional sobre tecnología aplicada al mundo de la medicina de la mano del Instituto Tecnológico de Massachusetts (MIT) y de la Fundación mVision. Este encuentro llevó por título 'La visión computacional se encuentra con la medicina'. Durante esta jornada, se analizó el impacto que están teniendo las nuevas técnicas de imagen en alta resolución para el diagnóstico de todo tipo de enfermedades.
Francisca Mulero-'La visión computacional se encuentra con la medicina'
Francisca Mulero-'La visión computacional se encuentra con la medicina'
Fundación Ramón Areces
IRRADIACION
s41598-020-75873-1.pdf
s41598-020-75873-1.pdf
HERRERAGAVINOLORIANG
Semelhante a Atherosclerotic plaque: Radionuclide Imaging
(20)
MCO 2011 - Slide 30 - K. Öberg - Spotlight session - Neuroendocrine tumours
MCO 2011 - Slide 30 - K. Öberg - Spotlight session - Neuroendocrine tumours
5. Carcinoid Tumour Biochemical And Radiological Testing
5. Carcinoid Tumour Biochemical And Radiological Testing
Basics and principles of PET.pptx
Basics and principles of PET.pptx
MCO 2011 - Slide 18 - M.R. Alison - Joint medics and nurses spotlight session...
MCO 2011 - Slide 18 - M.R. Alison - Joint medics and nurses spotlight session...
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...
Nuclear medicine
Nuclear medicine
2 2. hyung min chung ppt
2 2. hyung min chung ppt
Provenge (Sipuleucel T)
Provenge (Sipuleucel T)
Dr. Carlos García Echeverría - Simposio Internacional 'Terapias oncológicas a...
Dr. Carlos García Echeverría - Simposio Internacional 'Terapias oncológicas a...
From syngenic to_humanised_models_mirjolet_oncodesign
From syngenic to_humanised_models_mirjolet_oncodesign
A novel platform for in situ, multiomic, hyper-plexed analyses of systems bio...
A novel platform for in situ, multiomic, hyper-plexed analyses of systems bio...
Provenge (sipuleucel t)
Provenge (sipuleucel t)
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Cardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics
Cardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics
Nanotechnology in Cancer - Dr. Cote
Nanotechnology in Cancer - Dr. Cote
Update in Breast Imaging Radiopharmaceuticals
Update in Breast Imaging Radiopharmaceuticals
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
Development of a high throughput in vitro screening platform to identify nove...
Development of a high throughput in vitro screening platform to identify nove...
Francisca Mulero-'La visión computacional se encuentra con la medicina'
Francisca Mulero-'La visión computacional se encuentra con la medicina'
s41598-020-75873-1.pdf
s41598-020-75873-1.pdf
Atherosclerotic plaque: Radionuclide Imaging
1.
Atherosclerotic plaque:
Radionuclide Imaging Human Adams
2.
Introduction Genomics Proteomics
(complex) molecular pathways Atherosclerotic plaque Molecular ‘events’ Stenosis
3.
4.
5.
6.
7.
8.
Radionuclide imaging of
the plaque
9.
10.
11.
Radionuclide imaging of
the plaque: 18 F-FDG PET -CT JNM 16-3-’09
12.
Radionuclide imaging of
the plaque
13.
Radionuclide imaging of
the plaque: 18 F-FCH PET -CT JNM 16-3-’09 Matter et al
14.
15.
Radionuclide imaging of
the plaque: 125 I-MCP-1
16.
17.
18.
19.
20.
21.